Lingyun Lan
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Estrogen and related hormone effects, Cancer, Hypoxia, and Metabolism, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors
Most-Cited Works
- → Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs(2008)237 cited
- → Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302(2011)205 cited
- → Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment(2011)127 cited
- → Potent Antitubulin Tumor Cell Cytotoxins Based on 3-Aroyl Indazoles(2007)49 cited
- → Discovery of TH-302: An achiral hypoxia-activated cytotoxic prodrug(2007)4 cited
- In vitro activity profile of the novel hypoxia-activated cytotoxic prodrug TH-302(2008)
- → Supplementary Figure S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers(2025)
- → Supplementary Figure S6 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers(2025)
- → Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers(2025)
- → Supplementary Table S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers(2025)